IRIS
ARMENIA, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.050
EU - Europa 481
AS - Asia 252
AF - Africa 11
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 3.805
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.044
IT - Italia 171
SG - Singapore 162
IE - Irlanda 61
SE - Svezia 54
CN - Cina 52
DE - Germania 48
RU - Federazione Russa 35
GB - Regno Unito 25
UA - Ucraina 24
FR - Francia 16
KR - Corea 16
FI - Finlandia 11
BE - Belgio 10
CZ - Repubblica Ceca 9
VN - Vietnam 7
CM - Camerun 6
HK - Hong Kong 6
NL - Olanda 6
CA - Canada 4
PL - Polonia 4
CO - Colombia 3
ZA - Sudafrica 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
IR - Iran 2
MN - Mongolia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
EU - Europa 1
GR - Grecia 1
IN - India 1
JP - Giappone 1
KE - Kenya 1
MX - Messico 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.805
Salva come PNG Salva come JPEG
Città #
Wilmington 835
Houston 645
Woodbridge 500
Chandler 205
Singapore 132
Fairfield 125
Ann Arbor 77
Rome 71
Seattle 64
Ashburn 60
Dublin 58
Cambridge 45
Medford 41
Santa Clara 36
Beijing 33
New York 29
Dearborn 19
Lawrence 18
Munich 17
Creede 16
Colorado Springs 14
Jacksonville 14
Brussels 10
San Diego 9
Milan 8
Dong Ket 7
Florence 7
London 7
Brno 6
Los Angeles 6
Seoul 6
Boardman 5
Moscow 5
Nepi 5
Phoenix 5
Binasco 4
Cagliari 4
Council Bluffs 4
Helsinki 4
Hong Kong 4
Kraków 4
Mülheim 4
Perugia 4
Redwood City 4
Falmer 3
Magenta 3
Manitou Springs 3
Menlo Park 3
Nuremberg 3
Olomouc 3
Palo Alto 3
San Francisco 3
San Jose 3
Acton 2
Amsterdam 2
Avellino 2
Bologna 2
Cedarhurst 2
Durban 2
Durham 2
Kilburn 2
Kunming 2
Lappeenranta 2
Manchester 2
Milazzo 2
Nanjing 2
Quiliano 2
Roebling 2
Saint Petersburg 2
Santa Maria Capua Vetere 2
Sesto Fiorentino 2
São Paulo 2
Toronto 2
Verona 2
Villafranca Padovana 2
Xi'an 2
Yaoundé 2
Zhengzhou 2
Adliswil 1
Asti 1
Athens 1
Auckland 1
Bergamo 1
Berlin 1
Borås 1
Brescia 1
Brisbane 1
Calenzano 1
Casoria 1
Catania 1
Chengdu 1
Chicago 1
Chiswick 1
Civitanova Marche 1
Clearwater 1
Düsseldorf 1
Falkenstein 1
Frankfurt am Main 1
Fuzhou 1
Genova 1
Totale 3.275
Salva come PNG Salva come JPEG
Nome #
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 429
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 420
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 346
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 343
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen 333
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 305
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment 261
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 255
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 184
HIV MDR is still a relevant issue despite its dramatic drop over the years 174
Impact of integrase polymorphisms and minor quasispecies in HIV-1 infected individuals naive or treated with strand-transfer integrase inhibitors: a refined analysis by cloning and 454-pyrosequencing techniques 171
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 69
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 62
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 61
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 56
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries 53
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 51
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 47
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 42
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 38
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 38
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 33
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 32
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells 27
Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES study 25
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 24
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 21
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 21
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 18
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 16
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings 15
Totale 3.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.503
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020691 0 0 0 0 75 90 86 80 89 128 74 69
2020/2021672 76 77 81 78 70 83 81 56 8 28 18 16
2021/2022298 27 16 18 16 4 12 18 5 83 24 14 61
2022/2023531 44 62 51 55 57 75 22 76 44 22 12 11
2023/2024180 29 4 8 12 16 31 12 18 6 15 6 23
2024/2025388 31 157 113 56 31 0 0 0 0 0 0 0
Totale 3.970